The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Sjögrens Syndrome: The Need to Bridge Patient Symptoms & Objective Findings

Sjögrens Syndrome: The Need to Bridge Patient Symptoms & Objective Findings

November 17, 2015 • By Robert I. Fox, MD, PhD, & Carla M. Fox, RN

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The mainstay of dry eyes remains “artificial tears” and recognition/treatment of blepharitis. A trip to the local pharmacy will reveal an intimidating floor-to-ceiling display of an array of brands of artificial tear products that vary in preservative, “wetting agent” and price. The average rheumatologist offers the sage advice to “try a few different types and see what you like best.”

You Might Also Like
  • Patient Fact Sheet: Sjögren’s Syndrome
  • Researchers Look for Therapeutic Clues to Sjögrens Syndrome in Neural Pathways
  • Sjögren’s Syndrome Moves into the Spotlight
Explore This Issue
November 2015

Although we can advise about the latest genetic polymorphism reported in the journals, we remain clueless about how to advise the patient on rationally treating their ocular “disability.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

A wide variety of artificial tears have gone through clinical trials, and some promising new candidates are nearing FDA approval, but we will still have a wide gap between patient complaints and adequate therapy. Also, novel approaches, such as electrical stimulation of lacrimal glands, are being investigated.

However, I think the main breakthroughs in the next decade for the majority of SS patients will come with improved understanding of how the brain perceives the sensation of dryness at the cortical level (discussed below), because we see an enormous overlap between patients with symptoms and relatively few objective signs, and patients with dysfunctional tear films, but few symptoms.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The ocular receptors mediating dryness (evaporative loss) have been cloned, and their neural circuits have been mapped. However, the time has come to apply the lessons of neurochemistry and neuro­pathology to the humble task of “cracking the therapeutic code” of dry eye discomfort, which is not nearly as seductive a topic for research grants as demyelinating disorders, but has a much greater social and economic impact.

Dry mouth and dental decay remain enormous expenses (such as dental implants) that are not covered by medical or dental insurance. We do not have time to even take into account the disruptions of social interactions when patients cannot socialize around food with their friends and families. Given that approximately 90% of SS patients are female, this impact is critical.

Although not about Sjögren’s syndrome directly, the movie Eat Drink Man Woman, produced by Ang Lee, poignantly called attention to the important social relationships around food and socialization. This film examines the social interactions at family dinners and their importance in the culture and socialization of the family when the father (a chef) loses his ability to taste or smell the food he prepares. An SS patient cannot enjoy the same foods or even chew the same meat as others. Thus, their participation in the important social interactions around food is limited, and they withdraw from this important social support system, which is paramount to their overall emotional well-being.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 5 6 7 8 9 10 | Single Page

Filed Under: Conditions, Systemic Inflammatory Syndromes Tagged With: Clinical, Diagnosis, patient care, Research, Sjögren's syndrome, symptom, TreatmentIssue: November 2015

You Might Also Like:
  • Patient Fact Sheet: Sjögren’s Syndrome
  • Researchers Look for Therapeutic Clues to Sjögrens Syndrome in Neural Pathways
  • Sjögren’s Syndrome Moves into the Spotlight
  • Sjögren’s Syndrome: Beyond Dryness

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)